Participation rate or informed choice? Rethinking the European key performance indicators for mammography screening

Health Policy

Volumn 115, Issue 1, 2014, Pages 100-103

  Strech, Daniel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Ethics; Informed choice; Mammography screening; Participation rate; Performance indicator; Preference sensitive condition

Indexed keywords

BREAST NEOPLASMS; COST BENEFIT ANALYSIS; DECISION MAKING; EARLY DIAGNOSIS; EPIDEMIOLOGY; EUROPE; FEMALE; HEALTH CARE QUALITY; HUMAN; MAMMOGRAPHY; PATIENT ATTITUDE; PATIENT COMPLIANCE; STATISTICS AND NUMERICAL DATA;

BREAST NEOPLASMS; CHOICE BEHAVIOR; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; EUROPE; FEMALE; HUMANS; MAMMOGRAPHY; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; QUALITY INDICATORS, HEALTH CARE;

EID: 84894239429     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2013.11.012     Document Type: Article

References (29)

1. Gotzsche P.C., Nielsen M. Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews 2011, (1):CD001877.
2. Humphrey L.L., Helfand M., Chan B.K., Woolf S.H. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2002, 137:347-360.
3. Kalager M., Adami H.O., Bretthauer M., Tamimi R.M. Overdiagnosis of invasive breast cancer due to mammography screening: results from the norwegian screening program. Annals of Internal Medicine 2012, 156:491-499.
4. Berg W.A. Benefits of screening mammography. The Journal of the American Medical Association 2010, 303:168-169.
5. Independent UK Panel on Breast Cancer Screening The benefits and harms of breast cancer screening: an independent review. Lancet 2012, 380(9855):1778-1786.
6. Jorgensen K.J., Keen J.D., Gotzsche P.C. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality. Radiology 2011, 260:621-627.
7. Kopans D.B. The 2009 U.S. Preventive Services Task Force guidelines ignore important scientific evidence and should be revised or withdrawn. Radiology 2010, 256:15-20.
8. Gummersbach E., Piccoliori G., Zerbe C.O., Altiner A., Othman C., Rose C., et al. Are women getting relevant information about mammography screening for an informed consent: a critical appraisal of information brochures used for screening invitation in Germany, Italy, Spain and France. European Journal of Public Health 2010, 20:409-414.
9. Wegwarth O., Gigerenzer G. There is nothing to worry about: gynecologists' counseling on mammography. Patient Education and Counseling 2010, 84(2):251-256.
10. Wegwarth O., Schwartz L.M., Woloshin S., Gaissmaier W., Gigerenzer G. Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Annals of Internal Medicine 2012, 156:340-349.
11. Rimer B.K., Briss P.A., Zeller P.K., Chan E.C., Woolf S.H. Informed decision making: what is its role in cancer screening. Cancer 2004, 101:1214-1228.
12. Steckelberg A., Hulfenhaus C., Haastert B., Muhlhauser I. Effect of evidence based risk information on informed choice in colorectal cancer screening: randomised controlled trial. British Medical Journal 2011, 342:d3193.
13. Perry N., Broeders M., de Wolf C., Törnberg S., Holland R., von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis 2006, Health & Consumer Protection Directorate-General, Luxembourg. 4th ed.
14. Elwyn G., Frosch D., Thomson R., Joseph-Williams N., Lloyd A., Kinnersley P., et al. Shared decision making: a model for clinical practice. Journal of General Internal Medicine 2012, 27:1361-1367.
15. O'Connor A.M., Legare F., Stacey D. Risk communication in practice: the contribution of decision aids. British Medical Journal 2003, 327:736-740.
16. Oshima Lee E., Emanuel E.J. Shared decision making to improve care and reduce costs. The New England Journal of Medicine 2013, 368:6-8.
17. Kramer J.M. Balancing the benefits and risks of inhaled long-acting beta-agonists - the influence of values. The New England Journal of Medicine 2009, 360:1592-1595.
18. Wiener R.S., Gould M.K., Woloshin S., Schwartz L.M., Clark J.A. 'The thing is not knowing': patients' perspectives on surveillance of an indeterminate pulmonary nodule. Health Expectations: An International Journal of Public Participation in Health Care and Health Policy 2012, (online first).
19. Schwartz L.M., Woloshin S., Sox H.C., Fischhoff B., Welch H.G. US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. British Medical Journal 2000, 320:1635-1640.
20. Marteau T.M., Dormandy E., Michie S. A measure of informed choice. Health Expectations: An International Journal of Public Participation in Health Care and Health Policy 2001, 4:99-108.
21. Michie S., Dormandy E., Marteau T.M. The multi-dimensional measure of informed choice: a validation study. Patient Education and Counseling 2002, 48:87-91.
22. Klug S.J., Hetzer M., Blettner M. Screening for breast and cervical cancer in a large German city: participation, motivation and knowledge of risk factors. European Journal of Public Health 2005, 15:70-77.
23. Jørgensen K.G.P.C. Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. British Medical Journal 2004, 328:148-154.
24. Jorgensen K.J., Gotzsche P.C. Content of invitations for publicly funded screening mammography. British Medical Journal 2006, 332:538-541.
25. Domenighetti G., D'Avanzo B., Egger M., Berrino F., Perneger T., Mosconi P., et al. Women's perception of the benefits of mammography screening: population-based survey in four countries. International Journal of Epidemiology 2003, 32:816-821.
26. Gigerenzer G., Mata J., Frank R. Public knowledge of benefits of breast and prostate cancer screening in Europe. Journal of the National Cancer Institute 2009, 101:1216-1220.
27. Schwartz L.M., Woloshin S., Fowler F.J., Welch H.G. Enthusiasm for cancer screening in the United States. The Journal of the American Medical Association 2004, 291:71-78.
28. Edwards A.G., Evans R., Dundon J., Haigh S., Hood K., Elwyn G.J. Personalised risk communication for informed decision making about taking screening tests. Cochrane Database of Systematic Reviews 2006, (4):CD001865.
29. Epstein R.M., Alper B.S., Quill T.E. Communicating evidence for participatory decision making. The Journal of the American Medical Association 2004, 291:2359-2366.